These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18368994)

  • 1. The economic evaluation of prevention--let's talk about values and the case of discounting.
    Schwappach DL
    Int J Public Health; 2007; 52(6):335-6. PubMed ID: 18368994
    [No Abstract]   [Full Text] [Related]  

  • 2. [What to evaluate in prevention outcomes: Effectiveness, Cost-benefits, Cost-savings, Equity].
    Cislaghi C
    Epidemiol Prev; 2018; 42(5-6):372-375. PubMed ID: 30370741
    [No Abstract]   [Full Text] [Related]  

  • 3. Economic evaluation of prevention: we need to do better but first we need to sort out what the good is.
    Mooney G
    Int J Public Health; 2007; 52(6):339-40. PubMed ID: 18368996
    [No Abstract]   [Full Text] [Related]  

  • 4. [Economic aspects of prevention: an international perspective].
    Suhrcke M
    Gesundheitswesen; 2009 Oct; 71(10):610-6. PubMed ID: 19885761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic analysis of preventive medicine in Japan--based on two empirical studies.
    Kawabuchi K
    Jpn Hosp; 1997 Jul; 16():55-62. PubMed ID: 10174051
    [No Abstract]   [Full Text] [Related]  

  • 6. A review and analysis of the health and cost-effective outcome studies of comprehensive health promotion and disease prevention programs.
    Pelletier KR
    Am J Health Promot; 1991; 5(4):311-3. PubMed ID: 10148675
    [No Abstract]   [Full Text] [Related]  

  • 7. The economics of prevention.
    Simmons SJ
    ANA Publ; 1993 Nov; (CH-27 5M):1-9. PubMed ID: 7810849
    [No Abstract]   [Full Text] [Related]  

  • 8. The cost-effectiveness of environmental approaches to disease prevention.
    Chokshi DA; Farley TA
    N Engl J Med; 2012 Jul; 367(4):295-7. PubMed ID: 22830461
    [No Abstract]   [Full Text] [Related]  

  • 9. Epidemiological issues in health promotion and cost containment.
    Philips BV
    Health Values; 1988; 12(5):32-8. PubMed ID: 10312674
    [No Abstract]   [Full Text] [Related]  

  • 10. Counterpoint: uncertainty in the economic analysis of school-based obesity prevention programs: urgent need for quality evaluation.
    Wang LY; Yang Q; Lowry R; Wechsler H
    Obesity (Silver Spring); 2006 Sep; 14(9):1483-4. PubMed ID: 17030957
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness research on preventive interventions: a survey of the publications in 2008.
    van Gils PF; Tariq L; Verschuuren M; van den Berg M
    Eur J Public Health; 2011 Apr; 21(2):260-4. PubMed ID: 20534690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention: what is the cost?
    Turjanica MA
    Medsurg Nurs; 1995 Dec; 4(6):474-5, 478. PubMed ID: 8696396
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained economic value of a wellness and disease prevention program: an 8-year longitudinal evaluation.
    Schwartz SM; Mason ST; Wang C; Pomana L; Hyde-Nolan ME; Carter EW
    Popul Health Manag; 2014 Apr; 17(2):90-9. PubMed ID: 24156663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutting costs through prevention.
    Goldman E
    J Med Pract Manage; 2006; 22(1):41-4. PubMed ID: 16986640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The challenges of large-scale prevention and health promotion programs.
    Kohlmann T
    Int J Public Health; 2008; 53(2):67. PubMed ID: 18681334
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic and professional aspects of disease prevention and health promotion.
    Marshall EC
    J Am Optom Assoc; 1985 Sep; 56(9):692-7. PubMed ID: 4056291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A health economic evaluation of aspirin in the primary prevention of cardiovascular disease in Japan.
    Tsutani K; Igarashi A; Fujikawa K; Evers T; Kubin M; Lamotte M; Annemans L
    Intern Med; 2007; 46(4):157-62. PubMed ID: 17301509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The power of prevention and what it requires.
    Woolf SH
    JAMA; 2008 May; 299(20):2437-9. PubMed ID: 18505953
    [No Abstract]   [Full Text] [Related]  

  • 19. Economic evaluation of the benefits of cancer prevention and health promotion programs.
    Tager AM; Sondik EJ
    Md Med J; 1985 Jan; 34(1):77-82. PubMed ID: 3928998
    [No Abstract]   [Full Text] [Related]  

  • 20. [Polish forum for prevention guidelines on cardiovascular risk assessment].
    Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.